Navigation Links
Women Who Gain Excessive Weight During Pregnancy More Likely to Have Overweight Children
Date:6/8/2008

the Penn CCEB.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.


'/>"/>
SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
3. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
6. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
7. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
8. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
9. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Bay Area Women Sought for Egg Freezing Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...HESTER, Minn., Nov. 26 ...rd are at significantly increased risk of developi... findings of a Mayo Clinic study published this m...merican Academy of Pediatrics. , , The retr...7 patients with strabismus (misaligned eyes) and c...
(Date:11/26/2008)...dy Expanded to 406 Subjects , , FRANKLIN, M...s Inc. (OTC Bulletin Board: PLCSF) announced today...Food and Drug Administration (FDA) for its U.S. pi...any,s RenalGuard System(TM) and associated therap...y (CIN). , , The FDA also approved PLC,s re...
(Date:11/25/2008)...ISVILLE, Ky., Nov. 25 K...urgeons performed the fifth U.S. hand transplant o... at Louisville,s Jewish Hospital Hand Care Center ...began around noon and was completed shortly after ... http://www.newscom.com/cgi-bin/prnh/20081125/DC4...
(Date:11/25/2008)...TH SAN FRANCISCO, Calif., Nov. 25 ...velopment of novel therapeutics that target,prote...iseases, today,announced that data from two ongoi...iple myeloma will be presented at the upcoming 50t...ology (ASH). Carfilzomib is the first in a new cl...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 1Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 2Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 3Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 23343 1Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 23343 2Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference 23340 1Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference 23340 2Physicians Practice Promotes Key Executives 23337 1Physicians Practice Promotes Key Executives 23337 2
...t Randomized, Placebo-controlled Trial,Ever Conduc...linical Oncology, CHICAGO, June 04, 2007 /PRNewswi...ed, placebo-controlled clinical trial ever,conduct...L) showed,that ONTAK was more than twice as effect... patients with CTCL. [Abstract number 8026],The pr...
...With Follicular Lymphoma Reported,Today at ASCO An...ire/ -- GlaxoSmithKline plc,announced today long-t...e one-week course of frontline treatment with the ...ine I-131 Tositumomab) in,76 patients with newly d...a (NHL). This regimen was found to induce durable ...
Other Medicine Technology:Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
(Date:12/2/2008)...orld Wide Dictation Service, one of the premier le...ption, and legal dictation transcription, has joi... non-profit organization geared to the betterment ...amilies throughout Lower Westchester County, New Y...) December 3, 2008 -- World Wide Dictation Service...
(Date:12/2/2008)...oes your over-the-phone interpretation vendor cont...completed the call? , Was...orld of over-the-phone interpretation (OPI), every...er one minute can add up over the course of a bill...ganization employs an over-the-phone interpretatio...
(Date:12/2/2008)...rion Health announces that the SouthEast Alaska Re...a, has selected the Rhapsody™ Integration En...d, radiology, pharmacy, laboratory and business pr...to extend connectivity to statewide systems such a...ry) and AKAIMS (an MIS and clinical documentation ...
(Date:12/1/2008)... Including a patient,s ...meticulous reading from the radiologist interpreti...thetic approach, according to a study presented to...ety of North America (RSNA). , , "Our stud...ing and not as an anonymous case study," said lead...
Breaking Medicine News(10 mins):Health News:World Wide Dictation Service Teams up with TMATT for Local Thanksgiving Community Dinner 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 2Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 3
...ntified particular genes that are most prone to be...alled DNA promoter hypermethylation. Hypermethyla... normal cell development, to generate proteins tha...ehavior, or unregulated cell growth. So far, dat...
... between an extreme form of sleep disorder, REM Be...tia or parkinsonism. Patients with RBD have a hi...tia, Parkinsons disease or multiple system atrophy...pear to stem from a similar neurodegenerative orig...
...iasts and experts in the capital are strongly oppo...ng to recent reports of yet another application fi...l that the very idea of patenting knowledge like y..."Patenting of any kind is highly unjustified and w...
...age for mental illness does not increase usage and...who have children with mental illness, a Yale Scho... Services Research. Prior research has left polic...te parity laws will neither break the bank nor con...
Other Medicine News:Health News:Researchers Have Identified Cancer Promoter Genes 2Health News:Researchers Find Link Between Sleep Disorder and Dementia 2Health News:Yoga Enthusiasts Oppose Patenting Yoga Overseas 2Health News:Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending 2
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work.
Near PT test card/child recog/ playing cards 5 1/2" X 8".
Near point card/newspaper 8 to 48 point type 5 1/2" X 8".
Near point card 4 1/2 to 24 PT 5 1/2" x 8".
Medicine Products: